Will Jones

PHE Data Confirms That New Infections Peaked and Dropped in the Unvaccinated Before They Did in the Vaccinated

Back in early July I noted that data from the ZOE Covid Symptom Study was showing that new infections in the unvaccinated were peaking and falling while those in the vaccinated were still surging.

This was not a phenomenon noted elsewhere and prompted questions about whether it showed that the vaccines were delaying infection, or whether it was primarily an age-based phenomenon. Unfortunately, before anyone was able to investigate further, within a couple of weeks ZOE had ‘updated‘ their methodology and in their new data the phenomenon had oddly disappeared.

Alarming Data from PHE Shows the Fatality Rate in the Vaccinated Under-50s is 57% Greater Than in the Unvaccinated

Yesterday I wrote about the new data from Public Health England that allows us to make a (rough) calculation of vaccine efficacy during the Delta surge. Using data from technical briefings 17 and 20 I calculated that vaccine efficacy against infection with the Delta variant in the over-50s was a disappointing 17%. Vaccine efficacy against mortality was a better (if lower than expected) 77%.

The Daily Expose also published a piece looking at the new PHE data and argued that it showed vaccination was actually increasing the risk of hospitalisation and death. Their analysis did not break the results down by age, however, and so did not take into account that most of the infections are in the young, who are less vaccinated, and most of the deaths are in the old, who are much more vaccinated. That’s why my analysis focused on the over-50s, and when you do that you find the vaccines reduced mortality during the Delta surge in that age group by around 77%.

The Daily Expose article helpfully drew attention to the fact that in a recently published document, the Government advisers on SAGE themselves appear to admit that the vaccines do not prevent infection and transmission. In paragraph eight, they write:

While we feel that current vaccines are excellent for reducing the risk of hospital admission and disease, we propose that research be focused on vaccines that also induce high and durable levels of mucosal immunity in order to reduce infection of and transmission from vaccinated individuals. This could also reduce the possibility of variant selection in vaccinated individuals.

This being the case, why is SAGE not advising the Government to cease all aspects of the vaccination programme based on the idea of reducing transmission and protecting others (vaccine passports, the coercion of young people, vaccination of children and so on) as its members clearly don’t believe that these things are backed up by sound scientific evidence?

Devastating New Data From PHE Shows Vaccine Effectiveness Down to 17% and No Reduction in Infectiousness – But Mortality Cut by 77%

Public Health England yesterday released their latest technical briefing on the variants of concern, number 20, and it has some illuminating data.

It provides us with the infection, hospitalisation and death rates for the Delta variant, broken down by vaccination status and age. This allows us to do a calculation of the real-world vaccine effectiveness in the over-50s during the Delta surge, albeit a rough one without any adjustments.

The latest report has data up to August 2nd. If we substract from these values the data in Briefing 17 (up to June 21st) then we get the data covering the period June 22nd to August 2nd, which broadly corresponds to the bulk of the Delta surge in the U.K. The vaccine rollout to the over-50s was basically complete by this point, having stabilised according to PHE at around 88% double vaccinated and 10% unvaccinated (the other two per cent remaining single vaccinated, perhaps due to a bad reaction to the first dose).

In this period the PHE data tells us there were 2,464 Delta cases in the unvaccinated over-50s and 17,926 in the fully vaccinated over-50s. From this we can estimate the vaccine effectiveness against infection in the over-50s during the Delta surge as 17% (1-[(17,926/88%)/(2,464/10%)]). This confirms using additional data the estimate I made last week.

We can make a similarly rough calculation of the vaccine effectiveness against death. Between June 22nd and August 2nd, PHE reports that among the over-50s there were 339 deaths with the Delta variant in the double vaccinated and 167 in the unvaccinated. Using the same proportions vaccinated and unvaccinated as above, this gives a vaccine effectiveness against death in the over-50s during the Delta surge of 77% (1-[(339/88%)/(167/10%)]). Interestingly, this is very similar to the latest estimate of vaccine effectiveness against serious disease from Israel, which is around 80%. This is a decent level of protection and helps explain why the Delta surge had proportionally fewer hospitalisations and deaths, but it is well below the levels suggested by earlier studies and quoted by PHE, which are north of 95%.

What the Modellers Still Don’t Understand About Herd Immunity

Bristol’s Professor Philip Thomas has a new piece in the Spectator this week. Readers may recall that I criticised his previous pieces for what seemed in my view to be wildly over-the-top predictions of the likely scale of the Delta surge.

In June, he predicted “an enormous final wave“, in which the virus “would quickly seek out the one-in-three Britons who are still susceptible: mainly the not-yet-vaccinated” and peak in the middle of July (the bit he got right) “at anywhere between two million and four million active infections“. According to the ONS, around 951,700 people in the U.K. were PCR positive in the week ending July 24th, and that appears to be the peak, which is less than half of Professor Thomas’s lower estimate.

He now admits: “The situation is better than I bargained for at the beginning of June and also better than my estimates a month later.” In fact, it’s so much better, that he thinks “the decline in active infections can only mean that England is about to reach the herd immunity threshold for the Delta variant”. By which he means that “around 86% of England’s adults and children must now be immune”. On this basis he argues that it is “extremely unlikely” that there will be a new Covid surge in the coming winter.

The problem with this analysis is it is still based on the SAGE assumption that herd immunity is a once-for-all-time thing, that was made harder to reach by the more transmissible Delta variant, but which we have now just achieved, mostly through vaccination, and it will now keep us safe.

Public Health Scotland Adds 85 Unvaccinated Deaths in a Week as it “Updates” its Reporting

Last week I reported on the latest data from Public Health Scotland (PHS), which showed that 87% of the deaths added in the most recent week (July 9th-15th) were in the vaccinated (one or two doses) and 74% were in the double vaccinated. I estimated from this that the vaccine effectiveness against death was a surprisingly low 46%, though acknowledged that this was a very crude estimate based only on one week’s data.

This week’s update is now out from PHS, and the data is surprising to say the least. Whereas in the week July 9th-15th, 38 deaths were added, only five of which were in the unvaccinated, just one of those aged over 70, in the week July 16th-22nd, 141 deaths were added, 85 of them in the unvaccinated, 78 of those aged over 70. This kind of change from one week to the next is obviously anomalous and presumably reflects some kind of reporting artefact.

Indeed, it turns out that PHS announced an update to their COVID-19 reporting on July 28th, which they said would be reflected in this week’s report and would include a “one off increase in reported deaths”.

This means we can discount the weekly change implied by this week’s report and resume our effort to deduce the vaccine effectiveness against death from next week.

Latest Imperial REACT Report Finds Vaccine Effectiveness Could Be As Low as 22% – and Under-64s Are at Greater Risk of Hospitalisation Than Before the Vaccines

The report from round 13 of Imperial College’s REACT-1 Covid infection survey was published yesterday, covering the period from June 24th to July 12th, broadly corresponding to the Delta surge.

The press release led with the claim that “double vaccinated people were three times less likely than unvaccinated people to test positive for the coronavirus” (0.4% vs 1.2%). This is clearly misleading as an indication of vaccine effectiveness, however, as younger people were both less likely to be vaccinated and more likely to test positive. As the report itself admits: “These estimates conflate the effect of vaccination with other correlated variables such as age, which is strongly associated with the likelihood of having been vaccinated and also acts as a proxy for differences in behaviour across the age groups.”

Presumably, the headline was chosen by a politically savvy communications officer who did not want to draw attention to the fact that the study found a lower vaccine effectiveness than other studies such as those of Public Health England.

It found a vaccine effectiveness (vaccine type unspecified) among 18-64 year-olds of 49%. However, the 95% confidence interval ran from 22% to 67%, meaning the authors didn’t have enough positive test results to be very sure of their estimate (despite testing nearly 100,000 people, only 527 results or 0.54% came back positive). They couldn’t even be very confident it wasn’t as low as 22%.

America’s Delta Surge

New Covid infections are surging in America, driven by the Delta variant. The states which reopened in the spring, such as Texas, Mississippi and Georgia, and defied the predictions of catastrophic exit waves, are now seeing surges. Florida, too, which reopened last autumn, is seeing a spike in infections, and hospital admissions are rising.

Reuters takes a look at how states are responding – which is by doing remarkably little, with the appetite for restrictions even in Blue states now that the vaccines are rolled out seemingly much lower than in previous outbreaks.

News Round-Up

U.S. Congressmen’s Report: The “Preponderance of Evidence Proves” the Virus Leaked from the Wuhan Institute of Virology

A report from Republicans on the Foreign Affairs Select Committee of the U.S. Congress has said the “preponderance of evidence proves” the virus leaked from the Wuhan Institute of Virology “sometime before September 12th, 2019”.

The Telegraph summarises some of the main points of evidence.

The Republican report cited what it called under-reported information about laboratory safety protocols.

It detailed a request in July 2019 for a $1.5million overhaul of a hazardous waste treatment system, which was less than two years old. That request included maintenance on an “environmental air disinfection system”.

It raised questions about how well such systems were working in the months leading up to the outbreak, the report said.

The report said: “Such a significant renovation so soon after the facility began operation appears unusual.”

According to the report, satellite data in October showed a jump in visits to hospitals in Wuhan, along with a rise in people searching the internet for symptoms that could be linked to the virus.

It suggested the virus spread through Wuhan shortly before the Military World Games was held there in late October 2019.

In November, that event became an “international vector spreading the virus to multiple continents around the world” as athletes returned home, the report said.

The conclusions of this report are in line with earlier evidence set out on Lockdown Sceptics regarding the timeline of suspicious events and the smoking gun genetic evidence. This includes:

Vaccine Safety Update

This is the tenth of the regular round-ups of Covid vaccine safety reports and news compiled by a group of medical doctors who are monitoring developments but prefer to remain anonymous in the current climate (find the ninth one here). By no means is this part of an effort to generate alarm about the vaccines or dissuade anyone from getting inoculated. It should be read in conjunction with the Daily Sceptic‘s other posts on vaccines, which include both encouraging and not so encouraging developments. At the Daily Sceptic we report all the news about the vaccines whether positive or negative and give no one advice about whether they should or should not take them. Unlike with lockdowns, we are neither pro-vaccine nor anti-vaccine; we see our job as reporting the facts, not advocating for or against a particular policy. The vaccine technology is novel and the vaccines have not yet fully completed their trials, which is why they’re in use under temporary and not full market authorisation. This has been done on account of the emergency situation and the trial data was largely encouraging on both efficacy and safety. For a summary of that data, see this preamble to the Government’s page on the Yellow Card reporting system. (Dr Tess Lawrie recently wrote an open letter to Dr June Raine, head of the MHRA, arguing that: “The MHRA now has more than enough evidence on the Yellow Card system to declare the COVID-19 vaccines unsafe for use in humans,” a claim that has been “fact checked” here.) We publish information and opinion to inform public debate and help readers reach their own conclusions about what is best for them, based on the available data.

  • There have been international reports of adverse events following COVID-19 vaccines in Indonesia (reporting the deaths of 131 health care workers post Sinovac vaccine), India and Canada (reporting 22 cases of heart inflammation).
  • Further reports of Bell’s Palsy developing following vaccination, including a featured case report in the BMJ. Immunologist Dr. J. Bart Classen has written in the Journal of Medical – Clinical Research & Reviews on the risk of Parkinson’s disease following Covid vaccination, especially AstraZeneca (summarised here).
  • A study in the Lancet suggests that antibody responses wane rapidly and are low within two months of vaccination (though the authors note that protection via cellular immunity may remain).
  • A report on ‘breakthrough’ cases from NBC Boston, reporting 5,100 cases in Massachusetts and 80 subsequent deaths. 
  • The Royal College of Paediatrics and Child Health has said that it supports the recommendations of the JCVI on not vaccinating children below the age of 18 unless they have underlying health conditions.
  • The inventor of mRNA technology, Dr. Robert Malone, has spoken of his fear that current data shows a worrying trend of possible ADE (Antibody-Dependent Enhancement) as the vaccine may cause the virus to be more dangerous in the vaccinated than the unvaccinated.
  • Lawyers have warned that ‘ethical veganism’ is a protected belief that would be among those that would have to respected in any effort to introduce mandatory vaccination in workplaces, the Telegraph reports
  • Chief Midwife for England, Jacqueline Dunkley-Bent, has penned a letter to midwives, obstetricians and GP practices, asking them to recommend COVID-19 vaccines to pregnant women.  This follows some surveillance data that suggests some increased risk to pregnant women from the Delta variant. A study interim report published in the New England Journal of Medicine concludes that while 13% of the 827 vaccinated women in the study suffered a spontaneous abortion (miscarriage), this is not an elevated number. Dr. Peter McCullough has written in TrialSiteNews detailing some serious concerns with the study, stating: “The effect of the vaccines on early pregnancy losses (<20 weeks) is concerning and remains to be determined.” To date the Yellow Card system has reported 600 adverse events relating to pregnancy conditions including 10 deaths and 381 spontaneous abortions.
  • A Spanish preprint study in the Lancet suggests that the safety profiles of Pfizer and AstraZeneca vaccines are similar in terms of blood clotting. It also suggests that the risk of blood clotting is greater for those infected with SARS-CoV-2.
  • A preprint study in Medrxiv reports no difference in viral loads when comparing unvaccinated people to those who have ‘breakthrough’ infections post-vaccine, suggesting “that if vaccinated individuals become infected with the Delta variant, they may be sources of SARS-CoV-2 transmission to others”. 
  • Report in the Telegraph that AstraZeneca may end its future development of vaccines after offering its COVID-19 vaccine at cost to contribute to the pandemic effort. Pfizer, on the other hand, has reported record profits and is discussing increasing the costs of booster shots, according to the Guardian.
  • Statistician Mathew Crawford has argued that the CDC’s definition of a safety signal prevents it from picking up safety problems with the Covid vaccines, essentially because it compares the Covid vaccines to one another rather than to an established baseline.
  • VAERS – the American version of the Yellow Card reporting system – released new data on July 23rd bringing the total to 518,581 reports of 2,426,531 adverse events following Covid vaccines, including 11,940 deaths.
  • EudraVigilance – the equivalent of the Yellow Card reporting system in the EU – has logged (up to July 31st) 779,048 reports of 1,940,012 adverse events, including 20,595 deaths.
  • Suspected adverse events in the U.K. as reported in the media: Gemma O’Shea (35); Natalie Simpson (38).

Summary of Adverse Events in the U.K.

According to an updated report published on July 21st, the MHRA Yellow Card reporting system has recorded a total of 1,102,228 events based on 331,240 reports. The total number of fatalities reported is 1,517.

  • Pfizer (20.4 million first doses, 12.9 million second doses) now has one Yellow Card in 215 people vaccinated. Deaths: 1 in 43,777 people vaccinated (466).
  • AstraZeneca (24.7 million first doses, 23.2 million second doses) has one Yellow Card in 110 people vaccinated. Deaths: 1 in 24,263 people vaccinated (1,018).
  • Moderna (1.3 million first doses, 0.3 million second doses) has one Yellow Card in 118 people vaccinated. Deaths: 1 in 162,500 people vaccinated (8).